Adult products led Abbott ’s nutritional business sales growth in 2023 and likely will become a stronger driver in 2024 with the launch of a formulation for people using medications rapidly growing in popularity with the addition of a weight loss indication.
Sales of Abbott’s Ensure and Glucerna brands accounted for $1.05bn of the firm’s $2.04bn in total nutritionals sales for the fourth quarter, with adult product sales up 12.5% from the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?